Bleakley Financial Group, LLC Cooper Companies, Inc. Transaction History

Bleakley Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$306.88 - $380.0 $2,761 - $3,420	9 Added 0.75%	1,204 $456 Million
Q3 2023 Nov 14, 2023	SELL	$315.92 - $397.36 $6,950 - $8,741	-22 Reduced 1.81%	1,195 $380 Million
Q2 2023 Aug 14, 2023	BUY	$346.15 - $392.09 $7,269 - $8,233	21 Added 1.76%	1,217 $467 Million
Q1 2023 May 12, 2023	SELL	$323.56 - $373.36 $7,765 - $8,960	-24 Reduced 1.97%	1,196 $447 Million
Q4 2022 Feb 07, 2023	BUY	$248.67 - $334.17 $303,377 - $407,687	1,220 New	1,220 $403 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Bleakley Financial Group, LLC with notifications on news.